title: GnRH analogue-induced uterine shrinkage enabling a vaginal hysterectomy and repair in large leiomyomatous uteri.
abstract: Gonadotropin-releasing hormone (GnRH) analogue was used to reduce large leiomyomas in three young women who were scheduled to have an abdominal hysterectomy and vaginal plastic repair. Significant size decrease due to the hormonal treatment enabled safe vaginal hysterectomy and repair.
authors.affiliation: Department of Obstetrics and Gynecology, Assaf Harofeh Medical Center, Zerifin, Israel.
authors.forename: D
authors.initials: D
authors.lastname: Schneider
authors.forename: A
authors.initials: A
authors.lastname: Golan
authors.forename: I
authors.initials: I
authors.lastname: Bukovsky
authors.forename: M
authors.initials: M
authors.lastname: Pansky
authors.forename: E
authors.initials: E
authors.lastname: Caspi
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D007045:Hysterectomy, Vaginal; D007889:Leiomyoma / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D011300:Preoperative Care; D017329:Triptorelin Pamoate; D014594:Uterine Neoplasms / Q000188:drug therapy / Q000473:pathology* / Q000601:surgery; D014621:Vagina / Q000601:surgery
chemical_list: D000970:Antineoplastic Agents; D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone